zhonghua liu xing bing xue za zhi = zhonghua liuxingbingxue zazhi

Trials

Cureus

[1] Risk Factors for Pre-eclampsia and Eclampsia Disorders in Tertiary Care Center in Sukkur, Pakistan.

[2] pre-eclampsia and eclampsia: an update on the pharmacological treatment applied in portugal

[3] preeclampsia-eclampsia and future cardiovascular risk among women in taiwan

[4] pregnancy induced hypertension and feto-maternal outcome in a tertiary care hospital in eastern india: a prospective study

[5] correlation of serum neutrophil gelatinase associated lipocalin with disease severity in hypertensive disorders of pregnancy

[6] anti-convulsant therapy in eclampsia.

[7] Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases

[8] Serum magnesium and calcium in preeclampsia: a comparative study at the Korle-Bu Teaching Hospital, Ghana

[9] Risk factors and effective management of preeclampsia

[10] Nitric oxide dysregulation in the pathogenesis of preeclampsia among Ghanaian women

[11] Preeclampsia Induced Liver Dysfunction Complicated by Disseminated Intravascular Coagulopathy and Placental Abruption: A Case Report and Review of the Literature

[12] Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases

[13] Serum magnesium and calcium in preeclampsia: a comparative study at the Korle-Bu Teaching Hospital, Ghana

[14] Risk factors and effective management of preeclampsia

[15] Nitric oxide dysregulation in the pathogenesis of preeclampsia among Ghanaian women

[16] Prediction model development of late-onset preeclampsia using machine learning-based methods.

[17] Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus.

[18] Association of MTHFR C677T Polymorphism with Preeclampsia in North East of Iran (Khorasan Province).

[19] Placental Leucine Aminopeptidase- and Aminopeptidase A- Deficient Mice Offer Insight concerning the Mechanisms Underlying Preterm Labor and Preeclampsia

[20] [Association between both maternal and fetal angiotensinogen gene single nucleotide polymorphism and preeclampsia/eclampsia].

[21] Insufficient iodine nutrition status and the risk of pre-eclampsia: a protocol for systematic review and meta-analysis.

[22] Reduced ELABELA expression attenuates trophoblast invasion through the PI3K/AKT/mTOR pathway in early onset preeclampsia.

[23] Differential global and MTHFR gene specific methylation patterns in preeclampsia and recurrent miscarriages: A case-control study from North India.

[24] Hypoxia-induced Downregulation of SRC-3 Suppresses Trophoblastic Invasion and Migration Through Inhibition of the AKT/mTOR Pathway: Implications for the Pathogenesis of Preeclampsia

[25] Do the physiological aging of the placenta and the changes in angiogenesis marker sFlt-1 and PlGF concentrations predispose patients to late-onset preeclampsia?

[26] Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction.

[27] A Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth Restriction.

[28] Development of a focal segmental glomerulosclerosis after pregnancy complicated by preeclampsia: case report and review of literature.

[29] Circ_0063517 acts as ceRNA, targeting the miR-31-5p-ETBR axis to regulate angiogenesis of vascular endothelial cells in preeclampsia.

[30] Risk Factors for Pre-eclampsia and Eclampsia Disorders in Tertiary Care Center in Sukkur, Pakistan.

[31] Chemical elements and preeclampsia - An overview of current problems, challenges and significance of recent research.

[32] The Effects of Early-Onset Pre-Eclampsia on Placental Creatine Metabolism in the Third Trimester.

[33] Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia.

[34] Preeclampsia and the Ten-Year Risk of Incident Chronic Kidney Disease.

[35] Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia

[36] Frozen embryo transfer and preeclampsia: where is the link?

[37] Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia

[38] Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia

[39] Notching and Pulsatility Index of the Uterine Arteries and Preeclampsia in Twin Pregnancies

[40] Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia

[41] the obstetric history of preeclampsia as a further maternal cardiovascular risk factor

[42] diagnosis and prevention of preeclampsia using ultrasound doppler studies and hemostasis parameters

[43] a study of oral glucose tolerance test in preeclampsia

[44] preeclampsia is associated with increased central aortic pressure, elastic arteries stiffness and wave reflections, and resting and recruitable endothelial dysfunction

[45] pre-eclampsia and eclampsia: an update on the pharmacological treatment applied in portugal

[46] preeclampsia-eclampsia and future cardiovascular risk among women in taiwan

[47] intramural hematoma of the esophagus complicating severe preeclampsia

[48] la aspirina es ineficaz en la prevención de la pre-eclampsia

[49] avaliação hemodinâmica não invasiva de mulheres não grávidas, gestantes saudáveis e gestantes com pré-eclâmpsia usando biorreatância

[50] markers of insulin resistance and sedentary lifestyle are predictors of preeclampsia in women with adverse obstetric results

[51] pesando riscos e benefícios: lições aprendidas com as intervenções terapêuticas de um caso com pré-eclâmpsia grave balance entre beneficios y riesgos: lecciones aprendidas con las intervenciones terapéuticas de un caso con preclampsia grave balancing the benefits and risks: lessons learned from the therapeutic interventions of a case with severe preeclampsia

[52] ddavp might reduce the risk of preeclampsia in pregnant women with vwf defi ciency

[53] meta-analysis of aspirin for the prevention of preeclampsia: do the main randomized controlled trials support an association between low-dose aspirin and a reduced risk of developing preeclampsia?

[54] subarachnoid block for caesarean section in severe preeclampsia

[55] parity, education level and risk for (pre-) eclampsia in selected hospitals in jakarta

[56] circulating c19mc micrornas in preeclampsia, gestational hypertension, and fetal growth restriction

[57] cambios en la expresiÓn de los marcadores de disfunciÓn endotelial pal-1/pai-2 en preeclampsia leve y severa, y en gestantes normotensas sanas

[58] polimorfismos genéticos na pré-eclâmpsia gene polymorphisms in preeclampsia

[59] analysis of complement c3 gene reveals susceptibility to severe preeclampsia

[60] prevention of preeclampsia

[61] effect of folic acid supplementation in pregnancy on preeclampsia: the folic acid clinical trial study

[62] maternal and neonatal outcomes in women with preeclampsia

[63] the relationship between proteinuria in severe preeclampsia and maternal and fetal outcomes

[64] diagnosis and management of pre-eclampsia: an update

[65] relationship between syncytiotrophoblast microvillous membrane shedding in severe preeclampsia and rho/rock molecule expression

[66] renal involvement in preeclampsia: similarities to vegf ablation therapy

[67] avaliação dos fatores de risco maternos em gestantes admitidas com pré-eclâmpsia grave<br>doi: 10.20513/2447-6595.2016v56n2p25-29

[68] contemporary clinical management of the cerebral complications of preeclampsia

[69] predictors of cord blood leptin level in pregnancies complicated with preeclampsia, fetal growth restriction and in normal pregnancies

[70] pregnancy in the setting of asymptomatic non-cirrhotic chronic portal vein thrombosis complicated by pre-eclampsia

[71] dislipidemia en el sÍndrome de preemclapsia / dyslipidemia in preeclampsia syndrome

[72] anti-convulsant therapy in eclampsia.

[73] comparing post-traumatic stress disorder (ptsd) in primiparous and multiparous women with preeclampsia

[74] monocytes and macrophages in pregnancy and preeclampsia

[75] prevention of vascular dysfunction after preeclampsia: a potential long-term outcome measure and an emerging goal for treatment

[76] new approaches for preeclampsia: review of the literature

[77] the relationship between random urinary protein-to-creatinine ratio and 24-hours urine protein in diagnosis of proteinuria in mild preeclampsia

[78] The effect of antioxidants (vitmine E;C) on preeclampsia in primipar women

[79] Magnesium sulphate versus diazepam for eclampsia

[80] Comprehensive transcriptome mining identified the gene expression signature and differentially regulated pathways of the late-onset preeclampsia

[81] Serum protein profile analysis via label-free quantitation proteomics in patients with early-onset preeclampsia.

[82] Down-Regulation of CPEB4 Alleviates Preeclampsia through the Inhibition of Ferroptosis by PFKFB3.